Human insulin is being commercially produced from a transgenic species of
Option: 1
Rhizobium
Option: 2
Saccharomyces
Option: 3
Escherichia
Option: 4
Mycobacterium
Answers (1)
As we have already discussed in Biotechnological Application in Medicines - Genetically Engineered Insulin -
In 1983, Eli Lilly, an American company prepared two DNA sequences corresponding to A and B, chains of human insulin and introduced them in plasmids of E. coli to produce insulin chains.
Chains A and B were produced separately, extracted and combined by creating disulfide bonds to form human insulin.